Buy Xaggitin XL 18mg Prolonged-Release Tablets Online UK – Nova Meds UK

Xaggitin XL 18mg is a prolonged-release medicine containing methylphenidate hydrochloride. It is use as part of a comprehensive treatment programme for attention deficit hyperactivity disorder (ADHD) in eligible children aged six years and over and adults.

The prolonged-release formulation is design to release the active ingredient over an extended period. Treatment is individualise according to the patient’s symptoms, response to medication, medical history and tolerability.

At NOVA MEDS UK, our aim is to provide clear, responsible information to help patients understand prescription medicines and make informed decisions with their healthcare professionals.

Product Information

• Product name: Xaggitin XL 18mg Prolonged-Release Tablets
• Active ingredient: Methylphenidate hydrochloride
• Medicine category: Central nervous system stimulant
• Therapeutic use: ADHD management
• Formulation: Prolonged-release oral tablets
• Administration: Oral

For the official product information, consult the Xaggitin XL 18mg Patient Information Leaflet.

What Is Xaggitin XL 18mg Used For?

Xaggitin XL is prescribed to help manage ADHD symptoms as part of a wider treatment plan. ADHD can affect attention, concentration, impulse control and activity levels, potentially influencing everyday activities, education, work and relationships.

When clinically appropriate, methylphenidate may help improve attention and concentration and reduce impulsive behaviour. Medication is generally considered alongside psychological, educational and other supportive interventions.

A specialist should assess whether this medicine is suitable for the individual patient.

How Does Xaggitin XL Work?

Xaggitin XL contains methylphenidate, which affects certain chemical signalling processes in the brain associated with attention and behaviour.

Its prolonged-release formulation is designed to deliver the medicine over an extended period following a morning dose. The duration and degree of benefit can vary between individuals.

Xaggitin XL does not cure ADHD. Instead, it may help manage symptoms when used as prescribed and reviewed regularly by a healthcare professional.

Xaggitin XL 18mg Dosage and Administration

The appropriate dose depends on the patient’s age, previous ADHD treatment, response to medication and individual clinical needs.

For eligible patients who are not currently taking methylphenidate, 18mg once daily in the morning is a recommended starting dose under the product information. A prescriber may adjust the dose gradually when necessary.

Important dosage guidance:

• Take the medicine exactly as prescribed.
• It is generally taken once daily in the morning with water.
• Swallow the tablet whole; do not chew, crush, break or divide it.
• Do not increase, reduce or discontinue the dose without consulting the prescriber.
• Attend recommended follow-up appointments to monitor effectiveness and adverse effects.

The prescribed dose must not be assumed to be suitable for every patient. Consult the official patient information leaflet for further instructions.

Possible Side Effects

Like other medicines, Xaggitin XL can cause side effects, although not everyone experiences them.

Reported side effects include:

• Headache
• Difficulty sleeping
• Nervousness or anxiety
• Reduced appetite
• Stomach discomfort
• Nausea
• Dizziness
• Increased heart rate or palpitations
• Changes in mood

Contact your doctor if side effects persist, become troublesome or affect daily activities.

Seek urgent medical attention for serious symptoms, including chest pain, severe allergic reactions, significant changes in behaviour or mood, or symptoms suggesting a serious heart problem.

Important Safety Information

Before starting Xaggitin XL, tell your doctor about your medical history and all medicines you take.

Additional assessment or monitoring may be required for people with cardiovascular conditions, high blood pressure, seizure disorders, certain mental health conditions or a history of substance misuse.

Methylphenidate can interact with other medicines. In particular, it must not be taken with monoamine oxidase inhibitor (MAOI) antidepressants or within 14 days of stopping an MAOI.

Regular monitoring may include blood pressure, pulse, appetite, weight, growth in children and mental health.

Xaggitin XL is a prescription-only medicine and should only be use by the person for whom it has been prescribed. Never share it with another person.

Frequently Asked Questions

What is Xaggitin XL 18mg?

Xaggitin XL 18mg is a prolonged-release tablet containing methylphenidate hydrochloride, prescribed to help manage ADHD symptoms as part of a comprehensive treatment programme.

Is Xaggitin XL a stimulant?

Yes. Methylphenidate is a central nervous system stimulant that can help improve attention and concentration and reduce impulsive behaviour in people with ADHD.

How should Xaggitin XL 18mg be taken?

Taken once daily in the morning, as directed by the prescriber. The tablet should be swallowed whole and must not be crushed, chewed, broken or divided.

Can the dose be increased?

A prescriber may gradually adjust the dose according to treatment response and tolerability. Patients should never change their dose independently.

Can Xaggitin XL cause sleep problems?

Yes. Difficulty sleeping is a recognis side effect. Discuss persistent sleep difficulties with the prescribing clinician rather than changing the dose yourself.

Is Xaggitin XL available without a prescription in the UK?

No. Xaggitin XL is a prescription-only medicine. It should be obtain through an appropriate, regulated supply process following the required prescribing and clinical checks.

NOVA MEDS UK – Prescription Medicine Information

Visit NOVA MEDS UK for information about our website and pharmacy services.